Brief: Axovant Gene Therapies Announces Name Change To Sio Gene Therapies
Nov 10 (Reuters) - Axovant Gene Therapies Ltd AXGT.O :
* AXOVANT GENE THERAPIES ANNOUNCES NAME CHANGE TO SIO GENE
THERAPIES
* AXOVANT GENE THERAPIES LTD - NAME CHANGE EFFECTIVE
NOVEMBER 13,
2020
* AXOVANT GENE THERAPIES LTD - COMMON STOCK WILL TRADE ON
NASDAQ
UNDER NEW TICKER "SIOX" EFFECTIVE NOVEMBER 13, 2020
Source text for Eikon: ID:nGNXr78pQ
Further company coverage: AXGT.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Sio Gene Therapies
See all newsBrief: Sio Gene Therapies Inc - On March 14, Got Notice That Nasdaq Has Determined That Company's Common Stock Will Be Delisted From Nasdaq Capital Market
Brief: Sio Gene Therapies Announces Fiscal Third Quarter 2022 Financial Results
Brief: Sio Gene Therapies Inc. Announces Board Approval Of Plan Of Complete Liquidation, Dissolution
Brief: Sio Gene Therapies Announces Second Quarter Financial Results
Brief: Sio Gene Therapies Announces Fiscal First Quarter 2022 Financial Results